DNAzyme Biosensor for Ultrasensitive Analyte Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional biosensing methods based on molecular recognition elements (MREs) often fail to achieve high sensitivity for detecting low concentrations of biomarkers or harmful agents due to their reliance on binding interactions alone, necessitating the incorporation of signal-amplification mechanisms like rolling circle amplification (RCA), which increases cost and complexity.

Innovation Solution

A biosensor system utilizing a nucleic acid cleaving enzyme, such as an RNA-cleaving DNAzyme, that captures the cleavage product in a defined microzone, enriching its concentration through interaction with nucleic acid binding molecules, eliminating the need for enzymatic amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional biosensing methods based on molecular recognition elements are used, then the detection system is simple, but the sensitivity is insufficient for detecting low concentrations of biomarkers

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system separates the enzymatic amplification step from the detection step. The DNAzyme-catalyzed cleavage reaction is performed in solution to generate multiple cleavage products, which are then captured and concentrated on a solid support surface for detection. This segmentation eliminates the need for complex enzymatic amplification steps while maintaining high sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The nucleic acid cleavage product serves as an intermediary between the analyte recognition event and the final detection signal. The DNAzyme catalyzes the production of this intermediary product, which is then captured by the solid support, effectively translating the biochemical reaction into a detectable signal without requiring complex amplification enzymes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If enzymatic amplification such as rolling circle amplification is incorporated, then detection sensitivity is enhanced, but the cost and complexity of the assay increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay cost
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The system replaces expensive, delicate DNA polymerases required for rolling circle amplification with a more stable and cost-effective DNAzyme catalyst. The DNAzyme can be immobilized on inexpensive solid supports, eliminating the need for costly enzymatic reagents while achieving comparable or superior detection sensitivity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention changes the fundamental reaction parameter from enzymatic polymerization (RCA) to enzymatic cleavage (DNAzyme activity). This parameter change allows the use of more stable, cost-effective catalysts and simplifies the assay protocol while maintaining the ability to generate amplified signals through catalytic product formation.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If enzymatic amplification such as rolling circle amplification is incorporated, then detection sensitivity is enhanced, but the complexity of the assay increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay steps
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system merges the catalytic amplification function and the detection function into a unified platform. The DNAzyme-catalyzed cleavage reaction and the capture of cleavage products on the solid support occur in an integrated manner, eliminating the need for separate amplification and detection steps required by traditional RCA-based assays.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention extracts and eliminates the complex enzymatic amplification steps (such as DNA polymerase-based rolling circle amplification) from the assay protocol, retaining only the essential DNAzyme-catalyzed cleavage reaction and product capture steps. This extraction simplifies the overall assay while preserving detection sensitivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables ultrasensitive detection of analytes without the need for enzymatic amplification, reducing costs and complexity while achieving high sensitivity by concentrating the cleavage product, allowing for the detection of analytes at low concentrations.

Implementation Method 1

a nucleic acid cleaving enzyme is activated upon contact with the analyte, thereby cleaving the nucleic acid substrate to release a cleavage product

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

a second support containing a microzone covered with nucleic acid binding molecules such as DNA oligonucleotides capable of capturing a cleavage product through interaction such as Watson-Crick hybridization

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS11692215B2Nucleic acid cleaving enzyme-based biosensor and methods of use thereof
Publication Date: 2023.07.04 MCMASTER UNIV
  • US11692215B2 patent drawing
  • US11692215B2 patent drawing
  • US11692215B2 patent drawing

AI summary

This disclosure relates to biosensors, and in particular, biosensors based on nucleic acid cleaving enzymes such as ribonucleotide-cleaving DNAzymes for the detection of analytes, and methods of use.